This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow [Supplementary Material]
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lochner, H. V.
Right arrow Articles by Tornetta, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lochner, H. V.
Right arrow Articles by Tornetta, P., III
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 83:1650-1655 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.


Scientific Article

Type-II Error Rates (Beta Errors) of Randomized Trials in Orthopaedic Trauma

Heather V. Lochner, MSc, Mohit Bhandari, MDMSc and Paul Tornetta, III, MD

Investigation performed at Boston Medical Center, Boston, Massachusetts

Heather V. Lochner, MSc
Paul Tornetta III, MD
Department of Orthopaedic Surgery, Boston Medical Center, 850 Harrison Avenue, Dowling 2 North, Boston, MA 02118. E-mail address for P. Tornetta III: ptornetta{at}pol.net

Mohit Bhandari, MD, MSc
Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre, 1200 Main Street West, Room 2C12, Hamilton, ON L8N 3Z5, Canada. E-mail address: bhandari@sympatico.ca

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: Although an investigator may limit bias through randomization, concealment of patient allocation, and blinding, the results of randomized trials may be less convincing when the sample size is not sufficiently large to reveal a true difference between treatment groups. When the sample size is small, randomized trials are subject to beta errors (type-II errors)—that is, the probability of concluding that no difference between treatment groups exists when, in fact, there is a difference. The purpose of this study of randomized trials involving fracture care published between 1968 and 1999 was twofold: (1) to evaluate type-II error rates and study power (1 - β) for the primary outcomes and (2) to identify whether investigators clearly identified the primary and secondary outcomes.

Methods: To be eligible, studies were required to (1) be published in English, (2) be described as a randomized trial, (3) involve the care of adult patients with fractures, treated either operatively or nonoperatively, and (4) contain sufficient outcome information to enable study power to be calculated. Computer database searches were performed independently by two investigators to identify all potentially relevant study titles. Additional strategies to identify articles included (1) hand searches of selected orthopaedic journals from 1989 to 1999, (2) searches of the bibliographies of potentially relevant articles, and (3) review by content experts to identify missing studies. For each study, a standard power calculation was performed on the primary and secondary outcomes. For those studies in which the primary outcome was not explicitly reported, the most clinically relevant measure was chosen by consensus. Acceptable study power was agreed a priori to be 80% (type-I error of £ 0.20).

Results: We identified 620 potentially relevant citations from MEDLINE, of which only 187 were potentially eligible. We identified nine more articles with other searches, and application of the eligibility criteria to the 196 articles eliminated seventy-nine. Thus, we analyzed 117 studies in which a total of 19,942 patients with orthopaedic trauma had been randomized. Sample sizes ranged from ten to 662 patients (mean and standard deviation, 95 79 patients). The majority (34%) of trials involved the treatment of hip fractures. The mean overall study power among the 117 trials was 24.65% (range, 2% to 99%). The type-II error rate for primary outcomes was 90.52%.

Conclusions: Mean type-II error rates in the orthopaedic trauma trials that we analyzed exceeded accepted standards. Investigators can reduce type-II error rates by performing power and sample-size calculations prior to conducting a trial.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. Y. Yuen and J. E. Pope
Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials
Rheumatology, September 1, 2008; 47(9): 1367 - 1372.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
S. Morshed and M. Bhandari
Clinical Trial Design in Fracture-Healing Research: Meeting the Challenge
J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
The Canadian Orthopaedic Trauma Society
Open Reduction and Internal Fixation Compared with Circular Fixator Application for Bicondylar Tibial Plateau Fractures. Results of a Multicenter, Prospective, Randomized Clinical Trial
J. Bone Joint Surg. Am., December 1, 2006; 88(12): 2613 - 2623.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
S. R. Hurwitz, P. Tornetta III, and J. G. Wright
An AOA Critical Issue How to Read the Literature to Change Your Practice: An Evidence-Based Medicine Approach
J. Bone Joint Surg. Am., August 1, 2006; 88(8): 1873 - 1879.
[Full Text] [PDF]


Home page
JBJSHome page
J. S. Cummins, J. N. Weinstein, E. L. Peak, J. Parvizi, and R. H. Rothman
The Role of Patient Restrictions in Reducing the Prevalence of Early Dislocation Following Total Hip Arthroplasty * E.L. Peak, J. Parvizi, and R.H. Rothman reply:
J. Bone Joint Surg. Am., November 1, 2005; 87(11): 2587 - 2588.
[Full Text] [PDF]


Home page
JBJSHome page
C. Csimma and M. F. Swiontkowski
Large Clinical Trials in Musculoskeletal Trauma: Are They Possible? Lessons Learned from the International Study of the Use of Rhbmp-2 in Open Tibial Fractures
J. Bone Joint Surg. Am., January 1, 2005; 87(1): 218 - 222.
[Full Text] [PDF]


Home page
JBJSHome page
T. Bhattacharyya, P. TornettaIII, W. L Healy, and T. A Einhorn
The Validity of Claims Made in Orthopaedic Print Advertisements
J. Bone Joint Surg. Am., July 3, 2003; 85(7): 1224 - 1228.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
H. Lehtonen, T. L.N. Jarvinen, S. Honkonen, M. Nyman, K. Vihtonen, and M. Jarvinen
Use of a Cast Compared with a Functional Ankle Brace After Operative Treatment of an Ankle Fracture: A Prospective, Randomized Study
J. Bone Joint Surg. Am., January 29, 2003; 85(2): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. Bhandari, R. R. Richards, S. Sprague, and E. H. Schemitsch
The Quality of Reporting of Randomized Trials in The Journal of Bone and Joint Surgery from 1988 through 2000
J. Bone Joint Surg. Am., March 1, 2002; 84(3): 388 - 396.
[Abstract] [Full Text]